SCHEMBL18615380

SCHEMBL18615380

CC(C)(O)c1ccc2ccccc2c1-c1ccc2c(c1)C(C)(C)c1cc3c(cc1-2)C(C)(C)c1cc(-c2c(C(C)(C)O)ccc4ccccc24)ccc1-3

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.34
▸ GPR84 Q9NQS5 1/20 0.32
▸ HPGD P15428 2/20 0.32
▸ HSD17B10 Q99714 2/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ HIF1A Q16665 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ GLA P06280 1/20 0.31
▸ POLB P06746 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ ATM Q13315 1/20 0.31
▸ DNMT1 P26358 1/20 0.31
▸ PDK2 Q15119 5/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2128231 0.94 PDK2 (0.35) ALOX5DNMT1PDK2
SCHEMBL15505878 0.90 PDK2 (0.36) ALOX5GPR84PDK2KCNJ11
SCHEMBL18613008 0.81 ALOX5 (0.33) ALOX5HPGDCYP1A2CYP2D6CYP2C19
SCHEMBL13152865 0.79 ALOX5 (0.42) ALOX5GPR84HPGDHSD17B10CYP1A2
SCHEMBL29294794 0.78 PDK2 (0.40) PDK2
SCHEMBL15870870 0.76 MEN1 (0.43) HPGDHSD17B10CYP1A2CYP2D6CYP2C9
SCHEMBL19152597 0.76 ALOX5 (0.44) ALOX5CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL2132427 0.76 CYP2C9 (0.42) ALOX5GPR84HPGDHSD17B10CYP1A2
SCHEMBL18103622 0.76 CA12 (0.39) DNMT1
SCHEMBL14063310 0.76 HSD17B10 (0.45) HPGDHSD17B10CYP1A2CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11158816-B2 6,9,15,18-tetrahydro-s-indaceno[1,2-b:5,6-b′]difluorene derivatives and use thereof in electronic devices MERCK PATENT GMBH (DE) 2021-10-26 — — US disclosed
EP-3341349-B1 6,9,15,18-TETRAHYDRO-S-INDACENO[1,2-B:5,6-B']DIFLUORENE- DERIVATIVES AND THEIR USE IN ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2020-01-29 — — EP disclosed
WO-2017036574-A1 6,9,15,18-TETRAHYDRO-S-INDACENO[1,2-B:5,6-B']DIFLUORENE DERIVATIVES AND USE THEREOF IN ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2017-03-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11158816-B2 6,9,15,18-tetrahydro-s-indaceno[1,2-b:5,6-b′]difluorene derivatives and use thereof in electronic devices INF2, ETFB, INTS9 ALOX5 957/4885GPR84 4160/4885HPGD 565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback